MDPI and ACS Style
Bersani, M.; Failla, M.; Vascon, F.; Gianquinto, E.; Bertarini, L.; Baroni, M.; Cruciani, G.; Verdirosa, F.; Sannio, F.; Docquier, J.-D.;
et al. Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria. Pharmaceuticals 2023, 16, 1682.
https://doi.org/10.3390/ph16121682
AMA Style
Bersani M, Failla M, Vascon F, Gianquinto E, Bertarini L, Baroni M, Cruciani G, Verdirosa F, Sannio F, Docquier J-D,
et al. Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria. Pharmaceuticals. 2023; 16(12):1682.
https://doi.org/10.3390/ph16121682
Chicago/Turabian Style
Bersani, Matteo, Mariacristina Failla, Filippo Vascon, Eleonora Gianquinto, Laura Bertarini, Massimo Baroni, Gabriele Cruciani, Federica Verdirosa, Filomena Sannio, Jean-Denis Docquier,
and et al. 2023. "Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria" Pharmaceuticals 16, no. 12: 1682.
https://doi.org/10.3390/ph16121682